Pioglitazone treatment enhances resolution of neutrophilia and ameliorates inflammation in CGD mice. Mice were treated as described in Figure 4. The time course of neutrophilia was determined (A, with a blowup of the early time points shown in B), and cytokines were measured in lavage supernatants (CGD mice shown) (C). Data represent mean ± SE; N = 8 mice per time point. #P ≤ .02 compared with vehicle-treated CGD mice at the respective time points, and α,*P ≤ .01 compared with WT mice treated with vehicle, at the respective time points.